These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
587 related articles for article (PubMed ID: 18254756)
1. A case of onychomycosis due to Aspergillus sydowii diagnosed using DNA sequence analysis. Takahata Y; Hiruma M; Sugita T; Muto M Mycoses; 2008 Mar; 51(2):170-3. PubMed ID: 18254756 [TBL] [Abstract][Full Text] [Related]
2. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. Gupta AK; Lynde CW; Konnikov N J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119 [TBL] [Abstract][Full Text] [Related]
3. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. Gupta AK; Konnikov N; Lynde CW J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118 [TBL] [Abstract][Full Text] [Related]
4. Nail infection by Aspergillus ochraceopetaliformis. Brasch J; Varga J; Jensen JM; Egberts F; Tintelnot K Med Mycol; 2009; 47(6):658-62. PubMed ID: 19274598 [TBL] [Abstract][Full Text] [Related]
6. Toenail onychomycosis: current and future treatment options. Finch JJ; Warshaw EM Dermatol Ther; 2007; 20(1):31-46. PubMed ID: 17403258 [TBL] [Abstract][Full Text] [Related]
7. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis. Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272 [TBL] [Abstract][Full Text] [Related]
8. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents. Baudraz-Rosselet F; Ruffieux C; Lurati M; Bontems O; Monod M Dermatology; 2010; 220(2):164-8. PubMed ID: 20110639 [TBL] [Abstract][Full Text] [Related]
9. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature. Gupta AK; Gregurek-Novak T; Konnikov N; Lynde CW; Hofstader S; Summerbell RC J Cutan Med Surg; 2001; 5(3):206-10. PubMed ID: 11685666 [TBL] [Abstract][Full Text] [Related]
10. Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs. Torres-Rodríguez JM; Madrenys-Brunet N; Siddat M; López-Jodra O; Jimenez T J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):25-31. PubMed ID: 9731962 [TBL] [Abstract][Full Text] [Related]
12. Onychomycosis: first case due to Aspergillus nomius. Zotti M; Machetti M; Persi A; Barabino G; Parodi A Acta Derm Venereol; 2011 Sep; 91(5):591-2. PubMed ID: 21874220 [No Abstract] [Full Text] [Related]
13. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy. Del Rosso JQ J Am Osteopath Assoc; 1996 Oct; 96(10):607-9. PubMed ID: 8936929 [TBL] [Abstract][Full Text] [Related]
14. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus. Gupta AK; Gover MD; Lynde CW J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029 [TBL] [Abstract][Full Text] [Related]
15. The new oral antifungal agents for onychomycosis of the toenails. Gupta AK; Shear NH J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):1-13. PubMed ID: 10565624 [TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis. Havu V; Brandt H; Heikkilä H; Hollmen A; Oksman R; Rantanen T; Saari S; Stubb S; Turjanmaa K; Piepponen T Br J Dermatol; 1997 Feb; 136(2):230-4. PubMed ID: 9068738 [TBL] [Abstract][Full Text] [Related]